A New Roche Product: Executives
Cambridge, MA-based The Medicines Co. has had a low profile developing and selling products nobody else wanted. One company well-aware of the company is Roche, who lost several key executives to the start-up company and its develpoment partner MPM Capital. And Roche isn't happy about the high level raids.
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.